tert-Butyl methyl(2-(methylamino)ethyl)carbamate
CAS: 112257-19-9
Ref. 3D-FB143658
1g | 403.00 € | ||
2g | 550.00 € | ||
5g | 854.00 € | ||
250mg | 195.00 € | ||
500mg | 272.00 € |
Product Information
Tert-Butyl methyl(2-(methylamino)ethyl)carbamate (TBMMEC) is an experimental anticancer drug that has been shown to induce the regression of a variety of cancers in animal models. TBMMEC binds to the antigen Cetuximab and its conjugates, which have been found to be effective against colorectal cancer cells. TBMMEC has also been shown to inhibit the replication of human cytomegalovirus, a virus that causes cancer in humans. This drug is currently being tested for safety and efficacy in humans.
Chemical properties
Technical inquiry about: 3D-FB143658 tert-Butyl methyl(2-(methylamino)ethyl)carbamate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.